Mural Oncology plc
MURADelisted Dec 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001971543
Mural Oncology plc was delisted on Dec 5, 2025; its insiders filed their last Form 4 on Dec 5, 2025; 61 institutions reported holding it in 13F filings for Q3 2025, worth $11.0M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Mural Oncology plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −22 vs. Q4 2023
- Shares held
- 12.3M
- −1.10M (−8.3%) vs. Q4 2023
- Total value
- $59.9M
- −$19.1M (−24.2%) vs. Q4 2023
- New holders
- 16
- 14 more added
- Sold out
- 38
- 51 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 61 | $11.0M |
| Q2 2025 | 66 | $20.3M |
| Q1 2025 | 68 | $10.6M |
| Q4 2024 | 76 | $30.2M |
| Q3 2024 | 74 | $29.8M |
| Q2 2024 | 86 | $34.2M |
| Q1 2024 | 101 | $59.9M |
| Q4 2023 | 123 | $79.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Mural Oncology plc; share changes are against Q4 2023.